Science Explorer Interactive view Map
Topic · Rheumatology

IgG4-Related and Inflammatory Diseases

IgG4-Related and Inflammatory Diseases is a research topic within Rheumatology. Science Explorer counts 14k research works in it since 1950. 11.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and management of IgG4-related disease, including autoimmune pancreatitis, inflammatory myofibroblastic tumor, and sclerosing cholangitis. It discusses the diagnostic criteria, pathological features, clinical profiles, and therapeutic approaches such as rituximab therapy for this systemic disease.

  • IgG4-Related Disease
  • Autoimmune Pancreatitis
  • Inflammatory Myofibroblastic Tumor
  • Sclerosing Cholangitis
  • Diagnostic Criteria
  • Immunoglobulin G4
  • Pathological Features
  • Rituximab Therapy
  • Clinical Profile
  • Systemic Disease
Research works
14k
fractional, since 1950
In the world top 10%
1.5k
per year above
Top-10% rate
11.0%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+21%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead IgG4-Related and Inflammatory Diseases research?

By volume, the United States and China publish the most (533 and 491 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 533 works
  2. 2 China 491 works
  3. 3 Japan 340 works
  4. 4 India 202 works
  5. 5 Spain 98 works
  6. 6 Italy 94 works
  7. 7 United Kingdom 82 works
  8. 8 Türkiye 79 works
  9. 9 France 75 works
  10. 10 Germany 70 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 25.8%China: 23.8%Japan: 16.5%India: 9.8%6 others listed: 24.1%26%largest
United States533 · 25.8%China491 · 23.8%Japan340 · 16.5%India202 · 9.8%6 others listed498 · 24.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead IgG4-Related and Inflammatory Diseases research?

By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most IgG4-Related and Inflammatory Diseases research, followed by Capital Medical University and Peking Union Medical College Hospital.

By volume, 2022–2025

  1. 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 18 works
  2. 2 Capital Medical UniversityChina 15 works
  3. 3 Peking Union Medical College HospitalChina 15 works
  4. 4 All India Institute of Medical SciencesIndia 13 works
  5. 5 Peking UniversityChina 12 works
  6. 6 Mayo Clinic in ArizonaUnited States 11 works
  7. 7 Harvard UniversityUnited States 11 works
  8. 8 Mayo ClinicUnited States 10 works
  9. 9 Post Graduate Institute of Medical Education and ResearchIndia 10 works
  10. 10 Massachusetts General HospitalUnited States 10 works

Where is IgG4-Related and Inflammatory Diseases research done?

The largest centres of IgG4-Related and Inflammatory Diseases research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and New Delhi (India).

Largest cities, 2022–2025

  1. 1 Beijing China 111 works
  2. 2 Tokyo Japan 67 works
  3. 3 Shanghai China 38 works
  4. 4 New Delhi India 31 works
  5. 5 Seoul South Korea 29 works
  6. 6 Paris France 28 works
  7. 7 London United Kingdom 27 works
  8. 8 Chengdu China 26 works
  9. 9 Boston United States 25 works
  10. 10 Hangzhou China 24 works
See IgG4-Related and Inflammatory Diseases on the map

Where is the best place to study IgG4-Related and Inflammatory Diseases?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Capital Medical University and Post Graduate Institute of Medical Education and Research score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 10.4429%fractional works in this node (log) →share in the world top 10% →Chinese Academy of Medical Sciences & Peking Union Medical College: 18, 14.5%Capital Medical University: 16, 7.4%Post Graduate Institute of Medical Education and Research: 10, 6.9%Harvard University: 11, 25.7%All India Institute of Medical Sciences: 13, 2.5%Peking University: 12, 6.8%Sichuan University: 9, 9.3%Harvard UniversityChinese Academy of M…Capital Medical Univ…Post Graduate Instit…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 59.614.5%6.8×18 +133.2%
2 Capital Medical UniversityChina 50.57.4%9.9×16 +21.2%
3 Post Graduate Institute of Medical Education and ResearchIndia 45.66.9%10.9×10 +306.4%
4 Harvard UniversityUnited States 44.325.7%3.2×11 +12.9%
5 All India Institute of Medical SciencesIndia 34.92.5%8.0×13 +49.8%
6 Peking UniversityChina 29.36.8%2.7×12 +133.3%
7 Sichuan UniversityChina 10.89.3%2.0×9 +10.4%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is IgG4-Related and Inflammatory Diseases research growing?

Output in 2018–2022 was 21% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are IgG4-Related and Inflammatory Diseases.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.